OMS treatment amplified Mabc-induced expression of M1-related proinflammatory cytokines and inducible nitric oxide synthase, and significantly downregulated arginase-1 expression in murine macrophages. This evidence concerns the gene NOS2 and opsoclonus-myoclonus syndrome.